5:21 PM
 | 
May 11, 2007
 |  BC Extra  |  Financial News

EndoCeutics amends IPO

EndoCeutics (Quebec City, Quebec) lowered the proposed price range of its IPO and now hopes to sell 5.8 million shares at $7-$9 instead...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >